Cargando…
Assessment of liver cancer biomarkers
Liver cancer is the third cause of cancer-related deaths in the world. It is primarily divides into two main types, namely hepatocellular carcinoma (HC) and cholangiocarcinoma (IC). Due to the increasing number of patients with liver cancer and the high mortality rate, early diagnosis of the disease...
Autores principales: | Mansouri, Vahid, Razzaghi, Mohhamadreza, Nikzamir, Abdolrahim, Ahmadzadeh, Alireza, Iranshahi, Majid, Haghazali, Mehrdad, Hamdieh, Mostafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881406/ https://www.ncbi.nlm.nih.gov/pubmed/33585001 |
Ejemplares similares
-
Evaluation of long-term consumption of omeprazole disadvantages: a network analysis
por: Nikzamir, Abdolrahim, et al.
Publicado: (2020) -
Assessment of common and differentially expressed proteins between diabetes mellitus and fatty liver disease: a network analysis
por: Saki, Kourosh, et al.
Publicado: (2021) -
Introducing physical exercise as a potential strategy in liver cancer prevention and development
por: Zamanian-Azodi, Mona, et al.
Publicado: (2021) -
Suppressive Mechanisms Induced by Tregs in Celiac Disease
por: Asri, Nastaran, et al.
Publicado: (2020) -
Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach
por: Zamanian Azodi, Mona, et al.
Publicado: (2017)